IDEA Collider: Innovation & Asymmetric Learning in Pharma Creating Breakthroughs in Oncology: A Conversation with Susan Galbraith of AstraZeneca
In this episode of Idea Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge to spearheading transformative cancer treatments at AstraZeneca. She discusses pivotal moments in her career, AstraZeneca's vision for eliminating cancer as a cause of death, the role of patient stories in motivating R&D efforts, and the integration of emerging technologies like AI and digital health tools.
With a focus on collaboration and continuous learning, Susan provides insights into how successful oncology drugs are developed and the importance of equitable representation in clinical trials. Stay tuned for an engaging conversation that highlights the future of personalized cancer therapies and the collaborative efforts driving innovations in oncology.
Chapter Summaries;
00:00 Introduction and Guest Welcome
00:27 Susan Galbraith's Career Journey
02:37 Defining Success in Oncology R&D
05:01 Early Phase Drug Development
07:09 Digital Health and Patient Experience
12:37 Global Collaboration and Innovation
15:05 AI and Future of Oncology
28:08 Diversity and Inclusion in Clinical Trials
33:46 Mentorship and Career Advice
37:45 Challenges and Future Outlook in Oncology
42:06 Closing Remarks and Call to Action
Don't forget to Like, Share, Subscribe, Rate, and Review!
Keep up with Susan Gabraith;
Follow Mike Rea On;
- Website: https://www.ideapharma.com/
- X: https://x.com/ideapharma
- LinkedIn: https://www.linkedin.com/in/bigidea/
Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/